- Zacks Small Cap Research•15 days ago
FDA Determines InFoods is ‘Nonsignificant Risk’ Device: Eliminates Need for IDE Approval, Supports Expectation of De Novo Pathway…
- Capital Cube•last month
Click here to see latest analysisBiomerica, Inc. reports financial results for the quarter ended February 29, 2016.We analyze the earnings along side the following peers of Biomerica, Inc. – Align Technology, Inc., Pro-Dex, Inc., BIOLASE, Inc., DENTSPLY SIRONA, Inc. and Milestone Scientific Inc. (ALGN-US, PDEX-US, BIOL-US, XRAY-US and MLSS-US) that have also reported for this […] (Read more...) The post Biomerica, Inc. :BMRA-US: Earnings Analysis: Q3, 2016 By the Numbers : June 22, 2016 appeared first on CapitalCube.
Biomerica Inc.OTC BB
|Day's Range||0.00 - 0.00|
|Avg Vol (3m)||2,692|
As of 3:39 PM EDT. OTC BB Delayed Price. Market open.